WT1 and cancer: The Wilms' tumor antigen 1 (WT1) has been shown to be highly expressed and plays an oncologic role in various hematological and solid malignancies (51), but is negligibly expressed in normal tissues, thus making WT1 an ideal target for cancer immunotherapy strategies (52).